1. Home
  2. CDZI vs LXEO Comparison

CDZI vs LXEO Comparison

Compare CDZI & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$4.16

Market Cap

413.8M

Sector

Utilities

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$5.09

Market Cap

369.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
LXEO
Founded
1983
2017
Country
United States
United States
Employees
31
59
Industry
Water Supply
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
413.8M
369.8M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CDZI
LXEO
Price
$4.16
$5.09
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$18.44
AVG Volume (30 Days)
768.4K
714.3K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.81
EPS
N/A
N/A
Revenue
N/A
$654,000.00
Revenue This Year
$12.97
N/A
Revenue Next Year
$102.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.66
$2.51
52 Week High
$6.96
$10.99

Technical Indicators

Market Signals
Indicator
CDZI
LXEO
Relative Strength Index (RSI) 37.79 40.87
Support Level $4.15 $4.95
Resistance Level $5.10 $5.11
Average True Range (ATR) 0.24 0.43
MACD -0.03 -0.11
Stochastic Oscillator 20.30 31.83

Price Performance

Historical Comparison
CDZI
LXEO

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: